このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Dementia Management Training Programme for Primary Health Care Providers

2026年6月1日 更新者:Xinying Lin、Fujian Medical University

Application and Effectiveness of a RE-AIM-Based Dementia Management Competency Training Program for Primary Health Care Providers: A Cluster Randomized Controlled Trial

This study aims to evaluate the effectiveness and implementation outcomes of a dementia management competency training program for primary healthcare workers. A cluster randomized controlled trial will be conducted among primary healthcare institutions in Nanping, Fujian Province, China. Eligible primary health care providers will be recruited from community health service centers and township health centers.Participating institutions will be randomized in a 1:1 ratio to either a structured dementia management training group or a self-directed learning control group. The intervention group will receive a 12-week blended training program, including online learning, an in-person skills workshop, and case-based practice supervision. The control group will receive self-directed online learning materials. Outcomes will be assessed at baseline, immediately after the intervention, and 3 months after the intervention. The primary outcome is the change in dementia knowledge, measured using the Dementia Knowledge Assessment Scale. Secondary outcomes include dementia-related attitudes, dementia management practice competency, self-reported dementia management behaviors, objective screening and referral-related indicators, and implementation outcomes based on the RE-AIM framework.

調査の概要

詳細な説明

This study uses a hybrid effectiveness-implementation design integrating a cluster randomized controlled trial and implementation evaluation. The trial will assess the effectiveness of a dementia management competency training program for primary health care providers at both the individual and organizational levels. At the individual level, the study will evaluate the effects of the training on dementia knowledge, attitudes, practice competency, and dementia management-related clinical behaviors. At the organizational level, the study will examine reach, adoption, implementation quality, and maintenance of the training program in real-world primary healthcare settings.The study will be conducted in community health service centers and township health centers in Nanping, Fujian Province, China. Primary healthcare institutions will serve as clusters. Approximately 16 institutions will be recruited and randomized to the intervention or control group at a 1:1 ratio, with approximately 20 primary health care providers recruited from each institution.The intervention group will receive a 12-week structured blended training program named "Hand in Hand Along the Memory Path". During weeks 1-4, participants will complete seven online learning modules, with a total learning duration of approximately 3 hours. At the end of week 4, participants will attend an in-person skills workshop of approximately 2 hours, focusing on standardized use of cognitive screening and assessment tools. During weeks 5-12, participants will take part in online case-based supervision every two weeks and complete practice tasks related to cognitive screening and dementia management.The control group will receive self-directed online learning materials, including the same knowledge module videos and text-based materials. However, the control group will not receive structured learning tasks, case analysis, knowledge tests, demonstration videos, forum-based support, learning reminders, expert support, toolkits, in-person workshops, or case-based supervision.Quantitative data will be collected at baseline, immediately after the intervention, and 3 months after the intervention. Semi-structured interviews will be conducted 3 months after the intervention to explore participants' experiences, implementation barriers and facilitators, and factors affecting maintenance. Quantitative and qualitative findings will be integrated according to the RE-AIM framework.

研究の種類

介入

入学 (推定)

240

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

Primary healthcare workers aged 18 years or older

Registered healthcare professionals holding a formal license issued by the national health authority

At least 1 year of work experience

Able to access the internet using a computer, tablet, or mobile phone

Currently working in a participating community health service center or township health center

Willing to participate in the study and provide written informed consent

Exclusion Criteria:

Personnel who do not directly participate in patient disease management, including logistics or auxiliary staff

Interns, trainees, or students

Individuals currently participating in other similar dementia training interventions

Individuals planning to leave their current institution within the next 12 months

Individuals who refuse to participate in the study or decline to provide written informed consent

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:他の
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:トリプル

武器と介入

参加者グループ / アーム
介入・治療
実験的:Structured Dementia Management Training Group
Participants in this group will receive a 12-week structured blended dementia management competency training program. The program includes online learning modules, an in-person skills workshop, case-based supervision, and practice tasks designed to improve dementia knowledge, attitudes, practice competency, and dementia management-related behaviors among primary health care providers.
The intervention is a 12-week blended training program. During weeks 1-4, participants will complete seven online modules with a total learning duration of approximately 3 hours. At the end of week 4, participants will attend a 2-hour in-person skills workshop focusing on standardized cognitive screening and assessment. During weeks 5-12, participants will participate in online case-based supervision every two weeks and complete practice tasks, including cognitive screening records and dementia management case records.
他の名前:
  • "Hand in Hand on the Memory Journey" dementia management training programme
アクティブコンパレータ:Self-directed Learning Control Group
Participants in this group will receive self-directed online learning materials related to dementia management. The materials include knowledge module videos and text-based resources but do not include structured learning tasks, case analysis, knowledge tests, demonstration videos, forum-based support, learning reminders, expert support, toolkits, in-person workshops, or case-based supervision.
Participants will be provided with online dementia-related learning materials and will arrange their own learning time and place. No structured completion requirements, assessments, in-person activities, or expert supervision will be provided.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in dementia knowledge score
時間枠:Baseline, immediately after the intervention, and 3 months after the intervention
Dementia knowledge will be measured using the Dementia Knowledge Assessment Scale. The primary outcome is the change in total DKAS score from baseline to immediately after the 12-week intervention. Higher scores indicate greater dementia knowledge.
Baseline, immediately after the intervention, and 3 months after the intervention

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in dementia-related attitudes and confidence
時間枠:Baseline, immediately after the intervention, and 3 months after the intervention
Dementia-related attitudes and confidence will be measured using the General Practitioners' Attitudes and Confidence Scale for Dementia. Higher scores indicate more positive attitudes and greater confidence.
Baseline, immediately after the intervention, and 3 months after the intervention
Change in dementia management practice competency
時間枠:Baseline, immediately after the intervention, and 3 months after the intervention
Dementia management practice competency was measured using the Dementia Management Practice Competency Scale for Primary Care, which was developed by the research team. Higher scores on the scale indicate greater dementia management practice competency.
Baseline, immediately after the intervention, and 3 months after the intervention
Change in self-reported dementia management-related behaviors
時間枠:Baseline, immediately after the intervention, and 3 months after the intervention
Participants will report the frequency of dementia management-related behaviors during the past month, including cognitive screening, identification of suspected cognitive impairment, referral recommendation, communication with patients or family members, and dementia-related health education.
Baseline, immediately after the intervention, and 3 months after the intervention
Cognitive screening implementation rate
時間枠:Baseline, immediately after the intervention, and 3 months after the intervention
The cognitive screening implementation rate will be calculated as the number of patients aged 65 years or older who received cognitive screening divided by the total number of patients aged 65 years or older seen during the same period, multiplied by 100%.
Baseline, immediately after the intervention, and 3 months after the intervention
Referral recommendation documentation rate
時間枠:Baseline, immediately after the intervention, and 3 months after the intervention
The referral recommendation documentation rate will be calculated as the number of screen-positive patients with documented referral recommendations divided by the total number of screen-positive patients, multiplied by 100%.
Baseline, immediately after the intervention, and 3 months after the intervention

その他の成果指標

結果測定
メジャーの説明
時間枠
Online course completion rate
時間枠:Immediately after the intervention
The proportion of intervention group participants who complete all online learning modules.
Immediately after the intervention
In-person workshop attendance rate
時間枠:Immediately after the intervention
The proportion of intervention group participants who attend the in-person skills workshop.
Immediately after the intervention
Practice task completion rate
時間枠:Immediately after the intervention
The proportion of intervention group participants who submit the required screening records and case management records.
Immediately after the intervention
Online supervision participation rate
時間枠:Immediately after the intervention
The number of online supervision sessions attended divided by the number of scheduled supervision sessions.
Immediately after the intervention
Training satisfaction and acceptability
時間枠:Immediately after the intervention
Satisfaction and acceptability will be assessed using a self-designed questionnaire with Likert-scale items and open-ended questions.
Immediately after the intervention
Institutional maintenance of dementia-related practices
時間枠:3 months after the intervention
Institutional maintenance will be assessed using a questionnaire completed by institutional managers, including whether cognitive screening, result explanation, referral recommendation, or related training continues after the intervention.
3 months after the intervention
Barriers and facilitators to implementation and maintenance
時間枠:3 months after the intervention
Semi-structured interviews will be conducted with intervention group participants and institutional managers to explore implementation experiences, barriers, facilitators, and suggestions for optimization.
3 months after the intervention

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年6月15日

一次修了 (推定)

2026年9月15日

研究の完了 (推定)

2026年12月15日

試験登録日

最初に提出

2026年5月26日

QC基準を満たした最初の提出物

2026年5月26日

最初の投稿 (実際)

2026年6月1日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月3日

QC基準を満たした最後の更新が送信されました

2026年6月1日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する